Bioprocess Containers Market: Current Analysis and Forecast (2021-2027)

Region:Global

Author(s):

Product Code:UMHE21562

Download Sample Report download
Buy the Full ReportStarting from $3999
Published on

November 2021

Total pages

241

Table of Content

Download Sample Report download
Buy the Full ReportStarting from $3999

About the Report

About the Report

Bioprocess containers are flexile and single-use containers widely used in the Biopharmaceutical industry for the handling of sterile liquids, media preparation, and vaccine production. These containers are used for the storage of sterile containers and to speed up the ongoing biopharmaceutical process. In addition, these containers are less costly and are equipped with ports, fittings, tubing, and plastic films. In the production of biologics, the bioprocess containers are coupled with high-performance systems. These containers offer several advantages over the conventional stainless-steel system such as physical & chemical properties and biological compatibility. Bioprocess containers are widely exploited across pharma & biotech, bioresearch, consumer health, coatings & composites, and agro ingredients. They are also utilized for bioprocess systems, cell culture products, and drug discovery. Moreover, they lower energy costs, reduce chemical & water use, minimize cleaning validation efforts, and enable manufacturing flexibility.
The demand for the Bioprocess Containers market is burgeoning on account of the high demand for biologics, increasing production of vaccines with the aid of single-use disposable technology. The growing need for better, cheaper, and faster biologics production is fueling the growth of single-use technologies. Active development of individualized biologics and personalized medicines, including patient-specific cellular & gene therapies and therapeutic vaccines, demands high sterility and is therefore manufactured using single-use equipment and consumables. Moreover, the increasing biopharmaceutical R&D investments, and sustainability, as well as affordability of single-use bioprocess technology, are the other key factors driving the growth of the bioprocess containers market.
However, some of the restraints in the market are the issues related to leachable and extractable bioprocess containers, the high cost of instruments, and stringent regulatory policies towards the manufacturing process of bioprocess containers.
Based on Type, the market is fragmented into 2D bioprocess containers, 3D bioprocesses containers, and other containers and accessories. The 2D bioprocess containers segment dominated the market in 2020 and is expected to grow at lucrative growth. 2D bioprocess containers are frequently used in cell harvesting and for the transportation of bulk drug products and bulk drug precursors. In addition, it is also exploited for preparation and storage of buffer, culture medium and process fluid, and chromatography feed and fraction collection.
Based on Application, the market is fragmented into Upstream Processes, Downstream Processes, and Process Development. The Upstream Processes segment dominated the market in 2020 and is expected to grow at lucrative growth owing to the high use of bioprocess containers, particularly during fermentation and culture media processing. Upstream bioprocessing is the first phase of the bioprocess from cell line development and cultivation to culture expansion of the cells through harvest. Upstream bioprocessing has made great productivity gains over the last decade. Modern cell culture systems are now producing notably higher titers while also decreasing the time from bench to production bioreactor.
Based on End Users, the market is fragmented into Pharmaceutical & Biopharmaceutical Companies, CROs & CMOs, and Academic & Research Institutes. The Pharmaceutical & Biopharmaceutical Companies segment dominated the market in 2020 and is expected to grow at lucrative growth during the forecasted period. The demand for biopharmaceuticals among the elder population is growing owing to being more prone to various diseases that can be treated using biologics. As per WHO, by 2030, 1 in 6 people in the world will be aged 60 years or over. At this time the share of the population aged 60 years and over will increase from 1 billion in 2020 to 1.4 billion. By 2050, the world's population of people aged 60 years and older will double (2.1 billion). The number of persons aged 80 years or older is expected to triple between 2020 and 2050 to reach 426 million. This has resulted in the increasing focus of biopharmaceutical companies developing affordable biologics at lower costs. As bioprocess containers have wide applications in research & process development, the adoption of BPCs is increasing with the growth in the development and manufacturing of biologics and biosimilars.
For a better understanding of the market adoption of Bioprocess Containers, the market is analyzed based on its worldwide presence in the countries such as North America (United States, Canada, and the Rest of North America), Europe (Germany, France, Spain, United Kingdom and Rest of Europe), Asia-Pacific (China, Japan, India, Australia, and Rest of APAC), and Rest of World. North America is expected to dominate the Bioprocess Containers market on account of the rise in demand for biopharmaceutical products and strong R&D activities.
Some of the major players operating in the market include Thermo Fisher Scientific, Sartorius AG, GE Healthcare, Merck KGaA, Danaher, Lonza, Fenner, Meissner, Rim Bio, and Fluidscontrol. Several M&As along with partnerships have been undertaken by these players to boost their presence in different regions.

Products


Companies

Thermo Fisher Scientific, Sartorius AG, GE Healthcare, Merck KGaA, Danaher, Lonza, Fenner, Meissner, Rim Bio, and Fluidscontrol

Table of Contents

Table of Contents

1 MARKET INTRODUCTION

1.1. Market Definitions

1.2. Limitation

1.3. Stake Holders

1.4. Currency used in Report

2 RESEARCH METHODOLOGY OR ASSUMPTION

2.1. Research Process of the Bioprocess Containers Market

2.2. Research Methodology of the Bioprocess Containers Market

2.3. Forecasting Method

2.4. Respondent Profile

2.5. Main Objective of the Bioprocess Containers Market Study

3 MARKET SYNOPSIS

4 EXECUTIVE SUMMARY

5 GLOBAL BIOPROCESS CONTAINERS MARKET COVID-19 IMPACT

6 GLOBAL BIOPROCESS CONTAINERS MARKET REVENUE (USD BN), 2019-2027F

7 MARKET INSIGHTS BY TYPE

7.1. 2D bioprocess containers

7.2. 3D bioprocess containers

7.3. Other containers and accessories

8 MARKET INSIGHTS BY APPLICATION

8.1. Upstream Processes

8.2. Downstream Processes

8.3. Process Development

9 MARKET INSIGHTS BY END USERS

9.1. Pharmaceutical & Biopharmaceutical Companies

9.2. CROs & CMOs

9.3. Academic & Research Institutes

10 MARKET INSIGHTS BY REGION

10.1. North America Bioprocess Containers Market

10.1.1. United States

10.1.2. Canada

10.1.3. Rest of North America

10.2. Europe Bioprocess Containers Market

10.2.1. Germany

10.2.2. U.K.

10.2.3. France

10.2.4. Spain

10.2.5. Rest of Europe

10.3. Asia Pacific Bioprocess Containers Market

10.3.1. China

10.3.2. Japan

10.3.3. India

10.3.4. Australia

10.3.5. Rest of Asia Pacific

10.4. Rest of World Bioprocess Containers Market

11 BIOPROCESS CONTAINERS MARKET DYNAMICS

11.1. Market Drivers

11.2. Market Challenges

11.3. Impact Analysis

12 BIOPROCESS CONTAINERS MARKET OPPORTUNITIES

13 BIOPROCESS CONTAINERS MARKET TRENDS

14 LEGAL & REGULATORY FRAMEWORK

15 DEMAND AND SUPPLY SIDE ANALYSIS

15.1. Demand Side Analysis

15.2. Supply Side Analysis

15.2.1. Top Product Launches

15.2.2. Top Business Partnerships

15.2.3. Top Business Expansions, Investments and Divestitures

15.2.4. Top Merger and Acquisitions

16 VALUE CHAIN ANALYSIS

17 COMPETITIVE SCENARIO

17.1. Competitive Landscape

17.1.1. Company Shares, By Revenue

18 COMPANY PROFILED

18.1. Thermo Fisher Scientific

18.2. Sartorius AG

18.3. GE Healthcare

18.4. Merck KGaA

18.5. Danaher

18.6. Lonza

18.7. Fenner

18.8. Meissner

18.9. Rim Bio

18.10. Fluidscontrol

19 DISCLAIMER

You can also purchase parts of this report.
Do you want to check out a section wise price list?
Get Price Break-up

Why Buy From US?

RRR
Refine Robust Result (RRR) Framework

What makes us stand out is that our consultants follows Robust, Refine and Result (RRR) methodology. i.e. Robust for clear definitions, approaches and sanity checking, Refine for differentiating respondents facts and opinions and Result for presenting data with story

reach
Our Reach Is Unmatched

We have set a benchmark in the industry by offering our clients with syndicated and customized market research reports featuring coverage of entire market as well as meticulous research and analyst insights.

Research
Shifting the Research Paradigm

While we don't replace traditional research, we flip the method upside down. Our dual approach of Top Bottom & Bottom Top ensures quality deliverable by not just verifying company fundamentals but also looking at the sector and macroeconomic factors.

Insite
More Insights-Better Decisions

With one step in the future, our research team constantly tries to show you the bigger picture. We help with some of the tough questions you may encounter along the way: How is the industry positioned? Best marketing channel? KPI's of competitors? By aligning every element, we help maximize success.

Trust
Transparency and Trust

Our report gives you instant access to the answers and sources that other companies might choose to hide. We elaborate each steps of research methodology we have used and showcase you the sample size to earn your trust.

support
Round the Clock Support

If you need any support, we are here! We pride ourselves on universe strength, data quality, and quick, friendly, and professional service.

Why Client Choose Us?

400000+ Reports in repository
150+ Consulting project a year
100+ Analysts
8000+ Client Queries in 2022